These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 33215341)
1. Cytoreductive surgery in the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update. Domino JS; Ormond DR; Germano IM; Sami M; Ryken TC; Olson JJ J Neurooncol; 2020 Nov; 150(2):121-142. PubMed ID: 33215341 [TBL] [Abstract][Full Text] [Related]
2. The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update. Ziu M; Kim BYS; Jiang W; Ryken T; Olson JJ J Neurooncol; 2020 Nov; 150(2):215-267. PubMed ID: 33215344 [TBL] [Abstract][Full Text] [Related]
3. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma. Farrell C; Shi W; Bodman A; Olson JJ J Neurooncol; 2020 Nov; 150(2):269-359. PubMed ID: 33215345 [TBL] [Abstract][Full Text] [Related]
4. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of chemotherapeutic management and antiangiogenic treatment of newly diagnosed glioblastoma in adults. Redjal N; Nahed BV; Dietrich J; Kalkanis SN; Olson JJ J Neurooncol; 2020 Nov; 150(2):165-213. PubMed ID: 33215343 [TBL] [Abstract][Full Text] [Related]
5. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of cytoreductive surgery in the management of progressive glioblastoma in adults. Patrick HH; Sherman JH; Elder JB; Olson JJ J Neurooncol; 2022 Jun; 158(2):167-177. PubMed ID: 35246769 [TBL] [Abstract][Full Text] [Related]
6. The role of imaging for the management of newly diagnosed glioblastoma in adults: a systematic review and evidence-based clinical practice guideline update. Lundy P; Domino J; Ryken T; Fouke S; McCracken DJ; Ormond DR; Olson JJ J Neurooncol; 2020 Nov; 150(2):95-120. PubMed ID: 33215340 [TBL] [Abstract][Full Text] [Related]
7. The role of cytoreductive surgery in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. Ryken TC; Kalkanis SN; Buatti JM; Olson JJ; J Neurooncol; 2014 Jul; 118(3):479-88. PubMed ID: 24756348 [TBL] [Abstract][Full Text] [Related]
8. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Surgery in the Management of Adults With Metastatic Brain Tumors. Nahed BV; Alvarez-Breckenridge C; Brastianos PK; Shih H; Sloan A; Ammirati M; Kuo JS; Ryken TC; Kalkanis SN; Olson JJ Neurosurgery; 2019 Mar; 84(3):E152-E155. PubMed ID: 30629227 [TBL] [Abstract][Full Text] [Related]
9. The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline. Velázquez Vega JE; Brat DJ; Ryken TC; Olson JJ J Neurooncol; 2020 Nov; 150(2):143-164. PubMed ID: 33215342 [TBL] [Abstract][Full Text] [Related]
10. Congress of neurological surgeons systematic review and evidence-based clinical practice parameter guidelines for the treatment of adults with newly diagnosed glioblastoma: Introduction and Methods. Olson JJ; Ryken TC J Neurooncol; 2020 Nov; 150(2):87-93. PubMed ID: 33215339 [TBL] [Abstract][Full Text] [Related]
11. Combining 5-Aminolevulinic Acid Fluorescence and Intraoperative Magnetic Resonance Imaging in Glioblastoma Surgery: A Histology-Based Evaluation. Hauser SB; Kockro RA; Actor B; Sarnthein J; Bernays RL Neurosurgery; 2016 Apr; 78(4):475-83. PubMed ID: 26407129 [TBL] [Abstract][Full Text] [Related]
13. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery. Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704 [TBL] [Abstract][Full Text] [Related]
14. Combination of 5-ALA and iMRI in re-resection of recurrent glioblastoma. Quick-Weller J; Lescher S; Forster MT; Konczalla J; Seifert V; Senft C Br J Neurosurg; 2016 Jun; 30(3):313-7. PubMed ID: 26743016 [TBL] [Abstract][Full Text] [Related]
15. Gross total resection rates in contemporary glioblastoma surgery: results of an institutional protocol combining 5-aminolevulinic acid intraoperative fluorescence imaging and brain mapping. Schucht P; Beck J; Abu-Isa J; Andereggen L; Murek M; Seidel K; Stieglitz L; Raabe A Neurosurgery; 2012 Nov; 71(5):927-35; discussion 935-6. PubMed ID: 22895402 [TBL] [Abstract][Full Text] [Related]
16. 5-aminolevulinic acid guidance during awake craniotomy to maximise extent of safe resection of glioblastoma multiforme. Corns R; Mukherjee S; Johansen A; Sivakumar G BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26177997 [TBL] [Abstract][Full Text] [Related]
17. Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA-enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment. Coburger J; Engelke J; Scheuerle A; Thal DR; Hlavac M; Wirtz CR; König R Neurosurg Focus; 2014 Feb; 36(2):E3. PubMed ID: 24484256 [TBL] [Abstract][Full Text] [Related]
18. The Survival Advantage of "Supratotal" Resection of Glioblastoma Using Selective Cortical Mapping and the Subpial Technique. Esquenazi Y; Friedman E; Liu Z; Zhu JJ; Hsu S; Tandon N Neurosurgery; 2017 Aug; 81(2):275-288. PubMed ID: 28368547 [TBL] [Abstract][Full Text] [Related]
19. Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis. Coburger J; Segovia von Riehm J; Ganslandt O; Wirtz CR; Renovanz M World Neurosurg; 2018 Feb; 110():e389-e397. PubMed ID: 29138078 [TBL] [Abstract][Full Text] [Related]
20. Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. Pessina F; Navarria P; Cozzi L; Ascolese AM; Simonelli M; Santoro A; Clerici E; Rossi M; Scorsetti M; Bello L J Neurooncol; 2017 Oct; 135(1):129-139. PubMed ID: 28689368 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]